Celldex Therapeutics | CLDX - EPS Earnings Per Share


Celldex Therapeutics reported $-1.22 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -1.19 -0.71 Apr/30
FY2025Q4 Dec/2025 -1.22 -1 -0.71 Feb/25
FY2025Q3 Sep/2025 -1.01 -0.9 -0.64 Nov/10
FY2025Q2 Jun/2025 -0.85 -0.80 -0.54 Aug/07
FY2025Q1 Mar/2025 -0.71 -0.76 -0.56 May/05




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Agenus USD -0.3 0.84 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Celldex Therapeutics USD -1.22 0.21 Dec/2025
Glaxosmithkline GBP 0.21 0.51 Dec/2025
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Northwest Biotherapeutics USD -0.01 0.01 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Roche Holding CHF 8.37 2.95 Dec/2025